McKesson

WBA and McKesson's joint venture in Germany has WBA holding a 70% controlling equity interest, while McKesson holds the remaining 30% interest.

Two McKesson pharmacy executives have new roles under a recent realignment of how the company approaches its community pharmacy customers. 

More than 4,000 community pharmacies are immunizing this year.

The administration plans to use McKesson as its main distributor for a COVID-19 vaccine, which will be transported to distribution sites within 24 hours after the FDA grants an EU or approval.

In a DSN webinar, Nancy Lyons, chief pharmacist at Health Mart and vice president of pharmaceutical solutions and services at McKesson, highlighted how independent pharmacies are rising to the challenge amid COVID-19.

Chris Dimos, who has been in the industry since he started as a pharmacist in 1989, will retire from McKesson in September.

McKesson's new four-segment structure includes two new reportable segments — prescription technology solutions and international.

Bansi Nagji, previously McKesson's executive vice president and chief strategy and business development officer, will serve as GoodRx's president of health care.